David P. Ryan - Nov 1, 2022 Form 3 Insider Report for Cullinan Oncology, Inc. (CGEM)

Role
Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Stock symbol
CGEM
Transactions as of
Nov 1, 2022
Transactions value $
$0
Form type
3
Date filed
11/2/2022, 04:34 PM
Next filing
Jun 27, 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney